GeneDx Holdings Corp.

NasdaqGS:WGS Stock Report

Market Cap: US$2.1b

GeneDx Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:WGS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24SellUS$38,131,572OPKO Health, Inc.Company500,833US$80.16
20 Nov 24SellUS$3,316,880Jason RyanIndividual47,000US$72.26
18 Nov 24SellUS$10,393,723Mount Sinai School Of Medicine, Endowment ArmCompany147,141US$70.78
07 Nov 24SellUS$22,973,428OPKO Health, Inc.Company300,000US$77.22
31 Oct 24SellUS$64,935,000Mount Sinai School Of Medicine, Endowment ArmCompany865,800US$75.00
17 Sep 24SellUS$12,054,002OPKO Health, Inc.Company330,472US$38.29
23 Aug 24SellUS$5,007,094OPKO Health, Inc.Company144,826US$35.38
19 Aug 24SellUS$4,756,875OPKO Health, Inc.Company139,824US$34.49
13 Aug 24SellUS$2,898,314OPKO Health, Inc.Company84,774US$34.76
08 Aug 24SellUS$3,563,807OPKO Health, Inc.Company112,994US$31.82
31 Jul 24SellUS$2,976,346OPKO Health, Inc.Company88,839US$33.50
29 Jul 24SellUS$1,692,890OPKO Health, Inc.Company50,000US$33.86
26 Jul 24SellUS$4,560,363OPKO Health, Inc.Company135,000US$33.85
23 Jul 24SellUS$4,946,935OPKO Health, Inc.Company150,000US$33.46
17 Jul 24SellUS$823,188OPKO Health, Inc.Company25,000US$32.93
05 Jul 24SellUS$1,020,016OPKO Health, Inc.Company36,118US$28.24
03 Jul 24SellUS$2,457,286OPKO Health, Inc.Company89,082US$29.12
04 Jun 24BuyUS$2,757,117Casdin Capital, LLCCompany130,000US$22.52
29 May 24BuyUS$842,604Casdin Capital, LLCCompany40,000US$21.07
28 May 24BuyUS$3,424,989Casdin Capital, LLCCompany170,000US$20.61
13 May 24BuyUS$1,165,295Casdin Capital, LLCCompany50,000US$23.31
12 Mar 24SellUS$8,261Kareem SaadIndividual897US$9.21
12 Mar 24SellUS$24,111Katherine StuelandIndividual2,618US$9.21
12 Mar 24SellUS$8,574Kevin FeeleyIndividual931US$9.21
05 Mar 24BuyUS$357,652Casdin Capital, LLCCompany40,900US$8.83
03 Jan 24SellUS$271Kareem SaadIndividual105US$2.58

Insider Trading Volume

Insider Buying: WGS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of WGS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies333,1441.21%
Individual Insiders524,4631.91%
Public Companies1,393,5525.07%
Hedge Funds2,473,7819%
General Public3,133,58311.4%
VC/PE Firms3,507,16412.8%
Institutions16,105,71058.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.1%.

Top Shareholders

Top 25 shareholders own 71.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.8%
Casdin Capital, LLC
3,507,164US$271.5m-0.55%17.47%
9.9%
Mount Sinai School Of Medicine, Endowment Arm
2,719,692US$210.5m-27.1%94.63%
9%
Corvex Management LP
2,473,781US$191.5m0%6.41%
4.99%
OPKO Health, Inc.
1,370,841US$106.1m-36.9%no data
3.88%
BlackRock, Inc.
1,066,202US$82.5m15.3%no data
3.81%
Oracle Investment Management, Inc.
1,045,768US$80.9m-5.43%57.5%
3.75%
Goldman Sachs Group, Investment Banking and Securities Investments
1,030,068US$79.7m-2.07%0.04%
3.09%
The Vanguard Group, Inc.
849,442US$65.7m7.77%no data
2.09%
Millennium Management LLC
574,436US$44.5m84.5%0.04%
1.97%
Gagnon Securities, LLC
541,943US$41.9m-5.43%8.09%
1.72%
Driehaus Capital Management LLC
472,783US$36.6m9.03%0.22%
1.54%
Point72 Asset Management, L.P.
423,581US$32.8m81.5%0.08%
1.53%
Blackstone Inc.
420,715US$32.6m-49.6%0.13%
1.44%
Fred Alger Management, LLC
394,230US$30.5m0%0.13%
1.37%
Geode Capital Management, LLC
377,631US$29.2m8.75%no data
1.21%
CMLS Holdings LLC
333,144US$25.8m0%no data
1.2%
Assenagon Asset Management S.A.
329,256US$25.5m-10.1%0.04%
1.15%
State Street Global Advisors, Inc.
314,914US$24.4m18.3%no data
0.93%
Gagnon Advisors, LLC
255,059US$19.7m0%12.28%
0.82%
Voloridge Investment Management, LLC
224,382US$17.4m0%0.06%
0.81%
Lord, Abbett & Co. LLC
223,800US$17.3m9,100%0.05%
0.81%
Divisadero Street Capital Management, LP
221,944US$17.2m-1.43%1.83%
0.72%
Morgan Stanley, Investment Banking and Brokerage Investments
198,307US$15.3m-16.5%no data
0.71%
Joshua Ruch
194,267US$15.0m0%no data
0.7%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
192,351US$14.9m221%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 13:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GeneDx Holdings Corp. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC
Matthew SykesGoldman Sachs